BTIG to Host Virtual Biotechnology Conference on August 10-11, 2020
July 22, 2020Firm Event to Feature Key Opinion Leaders and More Than 120 Corporate Management Teams
NEW YORK–(BUSINESS WIRE)–BTIG announced today that the “BTIG Virtual Biotechnology Conference” will take place on Monday, August 10th through Tuesday, August 11, 2020. The conference will be hosted by BTIG Biotechnology Analysts Dae Gon Ha, PhD, Julian Harrison, Robert “Bert” Hazlett, and Thomas Shrader, PhD, CFA, as well as BTIG Healthcare Strategy and Franchise Sales Specialists Michael Karmiol, and Mikhail Keyserman, CMT, CFTe. BTIG expects to host more than 120 corporate management teams throughout the two-day, private event which includes thematic panels featuring key opinion leaders, fireside chats and one-on-one meetings.
Topics for discussion include:
- Solid Tumors: Are Cell, ADCs or Bi-mAbs the Next Frontier?
- Immuno-Oncology: Are We Closing in on Post PD1 Regimens?
- Advances in Neurosciences: Are There Useful Biomarkers?
- NASH: Does a Backbone Drug Need to Do More Than Control Lipids?
- KRAS Inhibition in Solid Tumors – Material Advancements and Continuing Challenges
“Our conference participants are developing and funding some of the most innovative and disruptive therapeutics, pharmaceuticals and technologies to care for patients today and in the future,” noted David Lenchus, Director of Research at BTIG. “We are thrilled about the lineup of speakers for our virtual event and look forward to helping clients make more informed investment decisions as they learn about industry trends and company-specific dynamics.”
BTIG’s Corporate Access program hosts client events across the consumer, energy, financials, healthcare, real estate, shipping and technology, media and telecommunications sectors.
For more information about the conference, email [email protected]. Please note that participants must be pre-registered to attend. To access BTIG insights, contact a BTIG representative or visit www.btigresearch.com.
About BTIG
BTIG is a global financial services firm specializing in institutional trading, investment banking, research and related brokerage services. With an extensive global footprint and more than 600 employees, BTIG, LLC and its affiliates operate out of 18 cities throughout the U.S., and in Europe, Asia and Australia. BTIG offers execution, expertise and insights for equities, equity derivatives, ETFs and fixed income, currency and commodities (futures, commodities, foreign exchange, interest rates, credit, and convertible and preferred securities). The firm’s core capabilities include global execution, portfolio, electronic and outsource trading, transition management, investment banking, prime brokerage, capital introduction, corporate access, research and strategy, commission management and more. Disclaimer: https://www.btig.com/disclaimer.
To learn more about BTIG, visit www.btig.com.
Contacts
Jill Gordon
646.818.9226
[email protected]
Amanda Gold
212.738.6134
[email protected]
BTIG to Host Virtual Biotechnology Conference on August 10-11, 2020
July 22, 2020Firm Event to Feature Key Opinion Leaders and More Than 120 Corporate Management Teams
NEW YORK–(BUSINESS WIRE)–BTIG announced today that the “BTIG Virtual Biotechnology Conference” will take place on Monday, August 10th through Tuesday, August 11, 2020. The conference will be hosted by BTIG Biotechnology Analysts Dae Gon Ha, PhD, Julian Harrison, Robert “Bert” Hazlett, and Thomas Shrader, PhD, CFA, as well as BTIG Healthcare Strategy and Franchise Sales Specialists Michael Karmiol, and Mikhail Keyserman, CMT, CFTe. BTIG expects to host more than 120 corporate management teams throughout the two-day, private event which includes thematic panels featuring key opinion leaders, fireside chats and one-on-one meetings.
Topics for discussion include:
- Solid Tumors: Are Cell, ADCs or Bi-mAbs the Next Frontier?
- Immuno-Oncology: Are We Closing in on Post PD1 Regimens?
- Advances in Neurosciences: Are There Useful Biomarkers?
- NASH: Does a Backbone Drug Need to Do More Than Control Lipids?
- KRAS Inhibition in Solid Tumors – Material Advancements and Continuing Challenges
“Our conference participants are developing and funding some of the most innovative and disruptive therapeutics, pharmaceuticals and technologies to care for patients today and in the future,” noted David Lenchus, Director of Research at BTIG. “We are thrilled about the lineup of speakers for our virtual event and look forward to helping clients make more informed investment decisions as they learn about industry trends and company-specific dynamics.”
BTIG’s Corporate Access program hosts client events across the consumer, energy, financials, healthcare, real estate, shipping and technology, media and telecommunications sectors.
For more information about the conference, email [email protected]. Please note that participants must be pre-registered to attend. To access BTIG insights, contact a BTIG representative or visit www.btigresearch.com.
About BTIG
BTIG is a global financial services firm specializing in institutional trading, investment banking, research and related brokerage services. With an extensive global footprint and more than 600 employees, BTIG, LLC and its affiliates operate out of 18 cities throughout the U.S., and in Europe, Asia and Australia. BTIG offers execution, expertise and insights for equities, equity derivatives, ETFs and fixed income, currency and commodities (futures, commodities, foreign exchange, interest rates, credit, and convertible and preferred securities). The firm’s core capabilities include global execution, portfolio, electronic and outsource trading, transition management, investment banking, prime brokerage, capital introduction, corporate access, research and strategy, commission management and more. Disclaimer: https://www.btig.com/disclaimer.
To learn more about BTIG, visit www.btig.com.
Contacts
Jill Gordon
646.818.9226
[email protected]
Amanda Gold
212.738.6134
[email protected]